Baidu
map

处方常用拉丁文缩写中文对照表

2019-07-10 不详 网络

盐水NS 糖水 GS 糖盐水GNS 地塞米松DEX

缩写字

拉丁文

中文

aa.
a.c.
a.d.
a.h.
a.j.
a.m.
a.p.
a.u.agit
Abs.febr.
Ac.;acid.
Ad.;add
Ad lid
Ad us.ext
Ad us.int.
Alt.die.(a.d.)

Amp.
Abt.ccen.
Aq.
Aq.bull
Aq.cal.
Ap.com
Ap.dest.
Ap.ferv.
Ap.font.
Ap.steril.
b.i.d.
Cap
Caps.amyl.
Caps.gelat.
Caps.dur.
Caps.moll.
Catapl.
c.c
c.g.
Cit.
Collum.
Collut.
Collyr.
Co.
Ccen.
Cons
Cort.
Crem.
c.t.
d.
d.d
d.i.d
d.in amp.
d.in caps.
Dec.
Deg.
Dest.
Dg.
Dieb.alt
Dil.
Dim.
Div.
Div.in p.
Div.inpar.aeg
d.t.d
Em.;emuls
Emp.
Ext
Extr.
Feb.urg
Fl.
Fol.
Fort.
Fr.
Garg.
g.;gm.
h.
Hb.
h.d.
h.s.
h.s.s
Hod.
In.d
Inf.
Inj.
i.h.
i.m.
i.v.
Lin.
Liq.
Lit.
Lot
Mist.
Ml.
Mg.
Muc.
N
n.et.m
Neb.
o.d.
O.D.
O.L.
O.S.
O.U.
Ol.
Om.bid.
Om.d.(o.d.)
Om.hor.(o.h.)
Om.man.
Om.noc.(o.n.)
p.c.
p.o.
Pil.
p.j.
p.m.
p.prand.
Pcoen.
Pro us.ext
Pro.us.int.
Pro us.med.
Pro us.vet.
Pulv.
Pt.
p.r.n.
q.d.
q.i.d.
q.h.
q.4.h.
q.l.
q.n.
q.s.

q.semih.
r.;rad
Rec
Rp.
Rhiz.
s.;sig.
s.i.d
s.l
s.o.s
Sem.
Ser.;syr.
Solut.
Semih.
Sp.
Stat.;st
Supp.
t.i.d.
t.;tr.
Troch.
Tab.
Us.
Ug.;ung.
Us.ext.
Us.int.
Ut dict
Vesp.

Ana
Ante cibos
Ante decubitum
Alternis horis
Ante jentaculum
Ante meridiem
Ante parndium
Ante usum agitetur
Absente febri
Acidum
Ad
Ad libitum
Ad usum externum
Ad usum internum
Alternis diebus
(alterno die)
Ampulla
Ante coenam
Aqua
Aqua bulliens
Aqua calida
Aqua communis
Aqua destillata
Aqua fervens
Aqua Fontana
Aqua sterilisata
Bis in die
Cape,capiat
Capsula amylacea
Capsula gelatinosa
Capsula dura
Capsula mollis
Cataplasma
Centimetrum cubicum
Centigramma
Cito
Collunarium
Collutorium
Collyrium
Compcitus
Coena
Consperus
Cortex
Cremor
Cutis testis
Da,dentur
De die
Dies in dies
Da in ampullis
Da in capsulis
Decoctum
Deglutio
Destillatus
Decigramma
Diebus alternis
Dilue,dilutus
Dimidius
Divide
Divide in partes
Divide inpartis aegualis
Da tales doses
Emulsum,emulsio
Emplastrum
Externus
Extractum
Febri urgente
Flos,flose
Folium folia
Fortis
Fructus
Gargarisma
Gramma,grammata
Hora
Herba
Hora decubitus
Hora somni
Hora somni sumendus
Hodie
In die
Inrfsum
Injectio
Injectio hypodermatica
Injectio musculosa
Injectio venosa
Inimentum
Liquor,liquidus
Litrum
Lotio
Mistura
Millilitrum
Milligramma
Mucilago
Nocte
Nocte et mane
Nebula
Omni die
Oculus dexter
Oculus laevus
Oculus sinister
Oculi utrigue
Oleum
Omni biduo
Omni die
Omni hora
Omni mane
Omni nocte
Post cibos
Per os
Pilula
Post jentaculum
Post meridiem
Post prandium
Post coenam
Pro usu externo
Pro usu interno
Pro usu medicinali
Prousu veterinario
Pulvis
Partes
Pro kre nata
Quaque die
Quarter in die
Quaque hora
Quaque 4 hora
Quantum libet
Quante nocte
Quantum sufficit
Quantum satis
Quaque semihora
Radix
Recens
Recipe
Rhizoma
Signa,signetur
Semel in die
Saccharum lactis
Si opus(est)sit
Semen
Sirupu,ssyrupus
Solutio
Semihora
Spiritus
Statim
Suppositouium
Ter in die
Tinctura
Trochscus
Tabella
Usus
Unguentum
Usus externus
Usus internus
Ut dictum
Vespere


饭前
睡前
每2小时,隔1小时
早饭前
上午,午前
午饭前
使用前振荡
不发烧时

到、为、加至
随意、任意量
外用
内服
隔日

安瓶(瓿)
晚饭前

开水,沸水
热水
普通水
蒸馏水
热水
泉水
无菌水
1日2次
应服用
淀粉襄
胶襄
硬胶襄
软胶襄
泥济
西西,公撮,立方公分
厘克,百分之一公分

洗鼻剂
漱口济
洗眼剂
复方的
晚饭
撒布剂

乳剂
皮试
给与,须给与
每日
每日,日日
给安瓿
给胶襄
煎剂
吞服
蒸馏的
分克
间日,每隔一日
稀释,稀的
一半
分开,分成
分……次服用
分成等分
给与此量
乳剂
硬膏(剂)
外部的
浸膏
发烧时


强的,浓的
果实
含漱剂

小时

睡觉时,就寝时
睡觉时
睡觉服用
今日
每日
浸剂
注射剂
皮下注射
肌肉注射
静脉注射
擦剂
溶液,液体的

洗剂
合剂
毫升
毫克
胶浆剂
夜晚
在早晚
喷雾剂
每日
右眼
左眼
左眼
双眼

每2日
每日
每小时
每日早晨
每日晚上
饭后
口服
丸剂
早饭后
午后
午饭后
晚饭后
外用
内用,内服
药用
兽医用
粉剂、散剂
部分
必要时
每日
每日4次
每1小时
每4小时
任意量
每日晚上
足够量
足够量,适量
每半小时

新鲜的

根茎
标记,指示
每日1次
乳糖
需要时
种子
糖浆
溶液
半小时
醵剂
立刻,立即
栓剂
每日3次
酊剂
锭剂,糖锭
片剂
应用,用途
软膏
外用
内服
依照嘱咐
晚上

常用医学英文缩写对照表

AB
ACEI
ACT
AG
AMI
ANA
ARDS
ASO
ATP
AVNRT
AVRT
BB
BEE
BT
BuN
C3
CBC
CCU
CHE
CK
CPAP
CPR
CT
CVP
DBP
DCT
DIC
DM
EF
ENT
FDP
FUO
GNS
Hb
HCO3-
HCT
HIV
Holter
IABP
IHSS
INR
IU
KPTT
KUB
LDH
NS

实际碳酸氢盐
血管紧张素转换酶抑制剂
激活凝血时间
离子间隙
急性心梗
抗核抗体
急性呼吸窘迫综合征
抗链球菌溶血素“0”
三磷酸腺苷
房室结折返性心动过速
房室折返性心动过速
缓冲碱
基础能量消耗
出血时间
尿素氮
补体C3
血常规
血管监护室
胆碱酯酶
肌酸磷酸激酶
持续正压通气
心肺复苏
凝血时间
中心静脉压
舒张压
双氢克尿噻
弥散性血管内凝血
舒张期杂音
射血分数
耳鼻喉科(五官科)
纤维蛋白原降解产物
不明原因发热
葡萄糖生理氯化钠溶液
血红蛋白
碳酸氢根
红细胞比容
人类免疫缺陷病毒
24h动态心电图
主动脉内气囊反搏术
特发性肥厚型主动脉瓣下狭窄
国际标准比率
国际单位
部分凝血活酶时间
腹部平片
乳酸脱氢酶
生理氯化钠溶液

NTG
OB
P(A-a)O2
P2
PaCO2
PAMPA
PaO2
PCAP
PCWP
PEEP
pH
PPD
Prn
PT
qh
qid
qn
qod
RF
RI
RR
S3
S4
SaO2
SB
TPN
SBE
SBP
SGOT
SGPT
SK
SM
T3
T4
TAT
TIL
tid
t-PA
TPN
TSH
UK
V/Q
VMA
WHO

硝酸甘油
隐油
肺泡气-动脉血氧分压差
肺动脉第二心音
动脉二氧化碳分压
氨甲苯酸
动脉氧分压
肺小动脉 压
肺毛细血管 压
呼气末正压
酸碱度
结核菌素纯蛋白衍生物
必要时
凝血酶原时间
每小时1次
每天4次
每晚1次
隔日1次
类风湿因子
胰岛素
呼吸频率
第3心音
第4心音
血氧饱和度
标准碳酸氢盐
肠外营养
亚急性细菌性心内膜炎
收缩压
血清谷草转氨酶
血清谷丙转氨酶
链激酶
收缩期杂音
三碘甲状原氨酸
甲状腺素
抗蛇毒血清
短暂脑缺血发作
每天3次
组织型纤溶酶原激活物
肠道外营养
促甲状腺激素
尿激酶
通气/灌注比
香草基杏仁酸
世界卫生组织

gtt
ID 皮内注射
H 皮下注射
IM 肌肉注射
IV 静脉注射

常用药品名称缩写简表

英文缩写

药品名称

英文缩写

药品名称

5Fu

5-氟脲嘧啶

6MP

6-巯基嘌呤

ACV

无环鸟苷

ADR

阿霉素

APC

复方阿斯匹林

Aza

硫唑嘌呤

BTX-A

A型肉毒毒素

CBZ

卡马西平

Cef

头孢呋辛钠

CEL

赛利洛尔

CIP

环丙沙星

CLX

头孢氨苄

CO SMZ

复方磺胺甲基异恶唑

CO VB

复方维生素B

CPZ

头孢哌酮

CsA

环孢素A

CZP

氯硝西泮

DMPPC

甲氧西林

DOC

多西紫杉醇

Dox

阿霉素

DRL

屈洛昔芬

EE

炔雌醇

EM

红霉素

EPO

促红细胞生长素

FOM

磷霉素

G-CSF

重组人粒细胞集落刺激因子

GL

格列齐特

Gli

格列吡嗪

GM

庆大霉素

GM1

单唾液酸四己糖神经节苷脂

GNS

葡萄糖钠盐

GS

葡萄糖

GTW

雷公藤多苷

HCL

盐酸黄酮哌酯

Ils

白细胞介素

IN

肌醇烟酸酯

LD

左旋多巴

LFX

洛非西定

LM

盐酸左旋咪唑

LMWH

低分子肝素

LNG

左炔诺孕酮

LTB4

白三烯B4

LTG

拉莫三嗪

LVFX

左氧氟沙星

MEBO

美宝湿润烧伤膏

MINO

米诺环素

MMC

丝裂霉素

MMF

霉酚酸酯

MP

甲泼尼龙

MZR

咪唑立宾

NK-104

伊它伐他汀

NM

硫酸新霉素

NS

生理盐水

NTL

奈替米星

OFLX

氧氟沙星

OTC

盐酸土霉素

PASNa

对氨基水杨酸钠

PB

苯巴比妥

PPA

盐酸苯丙醇胺

Pred

泼尼松

PSS

藻酸双酯钠

rhEGF

重组人表皮生长因子

rhG-CSF

重组人粒细胞集落刺激因子

RSG

罗格列酮

Ru486

米非司酮

SB

碳酸氢钠

SBT

舒巴坦

SD

磺胺嘧啶

SDM

磺胺邻二甲氧嘧啶

SFZSIZ

磺胺二甲异恶唑

SG

磺胺脒

SM2

磺胺二甲嘧啶

SMD

磺胺对甲氧嘧啶

SMM

磺胺间甲氧嘧啶

SMZ

磺胺甲基异恶唑

TAM

三苯氧胺

TC

盐酸四环素

TMP

甲氧苄氨嘧啶

TNZ

替硝唑

TOB

妥布霉素

TPM

托吡酯

VA

维生素A

VAD

维生素AD

VB1

维生素B1

VB12

维生素B12

VB2

维生素B2

VB6

维生素B6

VC

维生素C

VD

维生素D

VE

维生素E

VPA

丙戊酸钠

VPA

丙戊酸钠

盐水NS
糖水 GS
糖盐水GNS
地塞米松DEX

Amsacrine AMSA 胺苯丫啶
5-Azacytidine;Azacytidine AZCR 氮杂胞苷
Bleomycin BLM 博来霉素
Cyclophosphamide;Cytoxan CTX 环磷酰胺
Entoxan
Cisplatin;platin;Plationl
Cytarabine;Cytosine Arabinoside Cisp;
PDD;DDP Ara-C
顺氯胺铂
阿糖胞苷
Carmustine BCNU 卡氮芥
Adriamycin;Doxorubicin; ADM;ADR 阿霉素
Hydroxydounorubicin 放射菌素D
Dactinomycin;Actinomycin-D DACT Act-D 更生霉素

Daunorubicin DNR 柔红(毛)霉素
正定霉素、红比霉素
Dexamethasone DEX 地塞米松
Dacarbazine DTIC 甲氮咪胺
氮烯咪胺
Dianhydrogalactitol DAG 二去水卫矛醇
Etoposide p16. p16-213 鬼臼乙叉*
Epirubicicin;Pharmorubicin Epi-Dx;EADM 表阿霉素
5-Fluorouracil 5-Fu 5-氟脲嘧啶
Floxaridine 5-FudR 脱氧氟脲苷
5-氟脲嘧啶脱氧核苷
Flutamide(抗此激素类药) 氟烃甲基睾丸素
Fluoxymesterone 氟烃甲睾酮
Hydroxyurea HU 羟基脲
Hexamethymelamine HMM 六甲咪胺
Ifosfamide;Holoxan IFO 异环磷酰胺
Ketaconazole 酮康唑
Leucoorin;Folinic acid CF 甲酰四氢叶酸钙
Citroorum factor 荃氢叶酸钙
Lomustine CCNU 环巳亚硝脲
L-Asparaginase L-ASP 左旋门冬酰胺酶
Megestrole 甲地孕酮
Methotrexate MTX 胺甲喋呤
Mitomycin-C MMC 丝裂霉素
6-Mercaptopurine 6-MP 6疏基嘌呤
Mitoxantrone NT 米托蒽醌
L-Melphalan; 马法蓝
Phenylalanine mustard L-PAM 苯丙胺酸氮芥
Miototane O,P`DDD 二氯苯二氯乙烷
Dibromodulcitol;Mitolactol DBD 二溴卫矛醇
Plicamycin;Mithramycin MTH 光神霉素
Premarin (雌激素制剂)
Procarbazine PCZ;PCB 甲基苄肼
Semustine;Methyl-CCNU M-CCNU 甲环亚硝脲
Streptozotocin STZ 链脲霉素
Stilbestrol;Diethylstibestrol DES 己烯雌酚
Teniposide M-26 鬼臼噻吩*
6-Thioguanine 6-TG 6-疏鸟嘌呤
Tamoxifen TAM TXF 三苯氧胺
Thiophosphoramide Thio-Tepa 噻替哌
incristine CR 长春新碱
inblastine BL;LB 长春花碱
indictie DS 长春酰胺
Homoharringtonine HH 高三尖杉酯碱
Melphalan MEL 米尔法兰
Harringtonine HRT L-苯丙胺酸氮芥
三尖杉酯碱

部分常用药物拉丁文缩写

复方阿司匹林 A.P.C 异烟肼 INH 利福平 RFP
红霉素 EM 庆大霉素 GM 卡那霉素 KM
磺胺二甲嘧啶 SM 磺胺嘧啶 SD 磺胺甲基异噁唑 SMZ
长效磺胺 SDZ 甲氧苄啶 TMP γ -氨基丁酸 GABA
三磷酸腺苷 ATP 双氢氯噻嗪 DHCT 叶酸 FA
对氨基水杨酸钠 Nat.PAS 维生素 Vit 苯甲酸钠咖啡因 CNB
高锰酸钾 PP

碘解磷定 PM 肾上腺素 AD 多巴胺 DA
去甲肾上腺素 NA或NE 异丙肾上腺素 ISP 吡哌酸 PPA
促肾上腺皮质素 ACTH 甲状腺素 T4 甲苯磺丁脲 D860
柳氮磺胺吡啶 SAMP 甲氨蝶呤 MTX 氟尿嘧啶 5-UF
环磷酰胺 CTX 顺铂 DDP 卡介苗 BCG
转移因子 TF

AZI 阿奇霉素
CLA 克拉霉素
OFL 氧氟沙星
CIP 环丙沙星

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=900642, encodeId=d83190064208, content=有错误, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3385412798, createdName=ms7000001562401055, createdTime=Thu Nov 19 23:00:28 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894541, encodeId=ed0189454102, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50355385594, createdName=小小小小儿科, createdTime=Mon Oct 26 15:17:02 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884854, encodeId=3ba488485432, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/f639184716ee44bca2abab560b8eb177/507a6c8b5524403f932a12b066a83ec7.jpg, createdBy=9c8c5118046, createdName=1462cc31m13暂无昵称, createdTime=Sun Sep 13 05:20:45 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806149, encodeId=2dd88061499d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Aug 04 16:52:42 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803180, encodeId=582e803180b8, content=错了啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200718/1438a614a3d04f9f8501d24140dc2fa6/e869b1e270ae432789419afdba0e923b.jpg, createdBy=d6825296947, createdName=ms7000000335633074, createdTime=Sat Jul 18 10:47:55 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775470, encodeId=b1ad1e7547082, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri May 29 03:31:00 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877645, encodeId=52c918e764506, content=<a href='/topic/show?id=a9de56125fb' target=_blank style='color:#2F92EE;'>#拉丁文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56125, encryptionId=a9de56125fb, topicName=拉丁文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Feb 23 09:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=)]
    2020-11-19 ms7000001562401055

    有错误

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=900642, encodeId=d83190064208, content=有错误, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3385412798, createdName=ms7000001562401055, createdTime=Thu Nov 19 23:00:28 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894541, encodeId=ed0189454102, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50355385594, createdName=小小小小儿科, createdTime=Mon Oct 26 15:17:02 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884854, encodeId=3ba488485432, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/f639184716ee44bca2abab560b8eb177/507a6c8b5524403f932a12b066a83ec7.jpg, createdBy=9c8c5118046, createdName=1462cc31m13暂无昵称, createdTime=Sun Sep 13 05:20:45 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806149, encodeId=2dd88061499d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Aug 04 16:52:42 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803180, encodeId=582e803180b8, content=错了啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200718/1438a614a3d04f9f8501d24140dc2fa6/e869b1e270ae432789419afdba0e923b.jpg, createdBy=d6825296947, createdName=ms7000000335633074, createdTime=Sat Jul 18 10:47:55 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775470, encodeId=b1ad1e7547082, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri May 29 03:31:00 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877645, encodeId=52c918e764506, content=<a href='/topic/show?id=a9de56125fb' target=_blank style='color:#2F92EE;'>#拉丁文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56125, encryptionId=a9de56125fb, topicName=拉丁文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Feb 23 09:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=)]
    2020-10-26 小小小小儿科

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=900642, encodeId=d83190064208, content=有错误, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3385412798, createdName=ms7000001562401055, createdTime=Thu Nov 19 23:00:28 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894541, encodeId=ed0189454102, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50355385594, createdName=小小小小儿科, createdTime=Mon Oct 26 15:17:02 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884854, encodeId=3ba488485432, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/f639184716ee44bca2abab560b8eb177/507a6c8b5524403f932a12b066a83ec7.jpg, createdBy=9c8c5118046, createdName=1462cc31m13暂无昵称, createdTime=Sun Sep 13 05:20:45 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806149, encodeId=2dd88061499d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Aug 04 16:52:42 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803180, encodeId=582e803180b8, content=错了啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200718/1438a614a3d04f9f8501d24140dc2fa6/e869b1e270ae432789419afdba0e923b.jpg, createdBy=d6825296947, createdName=ms7000000335633074, createdTime=Sat Jul 18 10:47:55 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775470, encodeId=b1ad1e7547082, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri May 29 03:31:00 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877645, encodeId=52c918e764506, content=<a href='/topic/show?id=a9de56125fb' target=_blank style='color:#2F92EE;'>#拉丁文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56125, encryptionId=a9de56125fb, topicName=拉丁文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Feb 23 09:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=)]
    2020-09-13 1462cc31m13暂无昵称

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=900642, encodeId=d83190064208, content=有错误, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3385412798, createdName=ms7000001562401055, createdTime=Thu Nov 19 23:00:28 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894541, encodeId=ed0189454102, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50355385594, createdName=小小小小儿科, createdTime=Mon Oct 26 15:17:02 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884854, encodeId=3ba488485432, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/f639184716ee44bca2abab560b8eb177/507a6c8b5524403f932a12b066a83ec7.jpg, createdBy=9c8c5118046, createdName=1462cc31m13暂无昵称, createdTime=Sun Sep 13 05:20:45 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806149, encodeId=2dd88061499d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Aug 04 16:52:42 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803180, encodeId=582e803180b8, content=错了啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200718/1438a614a3d04f9f8501d24140dc2fa6/e869b1e270ae432789419afdba0e923b.jpg, createdBy=d6825296947, createdName=ms7000000335633074, createdTime=Sat Jul 18 10:47:55 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775470, encodeId=b1ad1e7547082, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri May 29 03:31:00 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877645, encodeId=52c918e764506, content=<a href='/topic/show?id=a9de56125fb' target=_blank style='color:#2F92EE;'>#拉丁文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56125, encryptionId=a9de56125fb, topicName=拉丁文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Feb 23 09:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=)]
    2020-08-04 phoebeyan520

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=900642, encodeId=d83190064208, content=有错误, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3385412798, createdName=ms7000001562401055, createdTime=Thu Nov 19 23:00:28 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894541, encodeId=ed0189454102, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50355385594, createdName=小小小小儿科, createdTime=Mon Oct 26 15:17:02 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884854, encodeId=3ba488485432, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/f639184716ee44bca2abab560b8eb177/507a6c8b5524403f932a12b066a83ec7.jpg, createdBy=9c8c5118046, createdName=1462cc31m13暂无昵称, createdTime=Sun Sep 13 05:20:45 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806149, encodeId=2dd88061499d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Aug 04 16:52:42 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803180, encodeId=582e803180b8, content=错了啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200718/1438a614a3d04f9f8501d24140dc2fa6/e869b1e270ae432789419afdba0e923b.jpg, createdBy=d6825296947, createdName=ms7000000335633074, createdTime=Sat Jul 18 10:47:55 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775470, encodeId=b1ad1e7547082, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri May 29 03:31:00 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877645, encodeId=52c918e764506, content=<a href='/topic/show?id=a9de56125fb' target=_blank style='color:#2F92EE;'>#拉丁文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56125, encryptionId=a9de56125fb, topicName=拉丁文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Feb 23 09:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=)]
    2020-07-18 ms7000000335633074

    错了啊!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=900642, encodeId=d83190064208, content=有错误, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3385412798, createdName=ms7000001562401055, createdTime=Thu Nov 19 23:00:28 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894541, encodeId=ed0189454102, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50355385594, createdName=小小小小儿科, createdTime=Mon Oct 26 15:17:02 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884854, encodeId=3ba488485432, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/f639184716ee44bca2abab560b8eb177/507a6c8b5524403f932a12b066a83ec7.jpg, createdBy=9c8c5118046, createdName=1462cc31m13暂无昵称, createdTime=Sun Sep 13 05:20:45 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806149, encodeId=2dd88061499d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Aug 04 16:52:42 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803180, encodeId=582e803180b8, content=错了啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200718/1438a614a3d04f9f8501d24140dc2fa6/e869b1e270ae432789419afdba0e923b.jpg, createdBy=d6825296947, createdName=ms7000000335633074, createdTime=Sat Jul 18 10:47:55 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775470, encodeId=b1ad1e7547082, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri May 29 03:31:00 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877645, encodeId=52c918e764506, content=<a href='/topic/show?id=a9de56125fb' target=_blank style='color:#2F92EE;'>#拉丁文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56125, encryptionId=a9de56125fb, topicName=拉丁文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Feb 23 09:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=)]
    2020-05-29 amyloid
  7. [GetPortalCommentsPageByObjectIdResponse(id=900642, encodeId=d83190064208, content=有错误, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3385412798, createdName=ms7000001562401055, createdTime=Thu Nov 19 23:00:28 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894541, encodeId=ed0189454102, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50355385594, createdName=小小小小儿科, createdTime=Mon Oct 26 15:17:02 CST 2020, time=2020-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884854, encodeId=3ba488485432, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/f639184716ee44bca2abab560b8eb177/507a6c8b5524403f932a12b066a83ec7.jpg, createdBy=9c8c5118046, createdName=1462cc31m13暂无昵称, createdTime=Sun Sep 13 05:20:45 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806149, encodeId=2dd88061499d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Tue Aug 04 16:52:42 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803180, encodeId=582e803180b8, content=错了啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200718/1438a614a3d04f9f8501d24140dc2fa6/e869b1e270ae432789419afdba0e923b.jpg, createdBy=d6825296947, createdName=ms7000000335633074, createdTime=Sat Jul 18 10:47:55 CST 2020, time=2020-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775470, encodeId=b1ad1e7547082, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri May 29 03:31:00 CST 2020, time=2020-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877645, encodeId=52c918e764506, content=<a href='/topic/show?id=a9de56125fb' target=_blank style='color:#2F92EE;'>#拉丁文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56125, encryptionId=a9de56125fb, topicName=拉丁文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Feb 23 09:31:00 CST 2020, time=2020-02-23, status=1, ipAttribution=)]

相关资讯

医院处方中一些常用拉丁文的缩写形式

aa.                 Ana 各 a.c.              &nb

常用处方拉丁文缩写

常用处方拉丁文缩写 a.c. 饭前 a.h. 每2h,隔1h a.j. 早饭前 a.m 上午 a.p. 午饭前 a.u.agit 使用前振荡 aa. 各 abs.febr 不发热时 ac.;acid- 酸 ad lib 随意,任意量 ad us.ext. 外用 ad us.int. 内服

Baidu
map
Baidu
map
Baidu
map